Drug information incorrect.
Duckmanton
L
L
D002170:Canada; D000075202:Contraindications; D004347:Drug Interactions; D005602:France; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy; D010080:Oxazoles / Q000493:pharmacokinetics* / Q000627:therapeutic use; D023303:Oxazolidinones; D011433:Propranolol / Q000493:pharmacokinetics; D017366:Serotonin Receptor Agonists / Q000493:pharmacokinetics* / Q000627:therapeutic use; D014363:Tryptamines; D014665:Vasodilator Agents / Q000493:pharmacokinetics
D010080:Oxazoles; D023303:Oxazolidinones; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; D014665:Vasodilator Agents; C089750:zolmitriptan; D011433:Propranolol